Enteric fever, encompassing typhoid and paratyphoid fever, is a systemic infection primarily caused by Salmonella Typhi and Salmonella Paratyphi. Despite advancements in medical science, its diagnosis and management continue to pose challenges due to varying clinical manifestations and increasing antibiotic resistance.
Early diagnosis is crucial for effective management of enteric fever. Blood culture remains the gold standard for diagnosis, although it has limitations such as time consumption and low sensitivity. Other diagnostic modalities include bone marrow culture, stool culture, and serological tests like Widal test. However, these have their own set of limitations. Recent advancements include molecular techniques like PCR, which provide rapid and accurate results.
The increasing resistance of Salmonella species to first-line antimicrobials like chloramphenicol, ampicillin, and co-trimoxazole has necessitated the use of second-line drugs such as fluoroquinolones and cephalosporins. However, emerging resistance to these drugs has been reported. Therefore, susceptibility testing is essential for appropriate antimicrobial selection.
Vaccination plays a significant role in enteric fever prevention. Two vaccines, Vi polysaccharide vaccine and Ty21a vaccine, are currently available. Both vaccines provide a reasonable degree of protection and are recommended for travelers to endemic areas and high-risk populations.
In conclusion, enteric fever remains a significant global health issue. Early diagnosis and appropriate antimicrobial therapy are vital for successful management. Emerging diagnostic techniques and vigilant antimicrobial stewardship can help overcome the challenges posed by this disease. Vaccination remains an important preventive measure. Continuous research and development in these areas are crucial for the effective control and eventual eradication of enteric fever.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation